PL430029A1 - Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehydu - Google Patents
Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehyduInfo
- Publication number
- PL430029A1 PL430029A1 PL430029A PL43002917A PL430029A1 PL 430029 A1 PL430029 A1 PL 430029A1 PL 430029 A PL430029 A PL 430029A PL 43002917 A PL43002917 A PL 43002917A PL 430029 A1 PL430029 A1 PL 430029A1
- Authority
- PL
- Poland
- Prior art keywords
- escin
- subject
- present
- acetaldehyde toxicity
- extract
- Prior art date
Links
- AXNVHPCVMSNXNP-IVKVKCDBSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(e)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AXNVHPCVMSNXNP-IVKVKCDBSA-N 0.000 title abstract 6
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 title abstract 6
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 title abstract 6
- 229940093314 beta-escin Drugs 0.000 title abstract 6
- AXNVHPCVMSNXNP-BEJCRFBNSA-N beta-escin Natural products CC=C(/C)C(=O)O[C@H]1[C@H](OC(=O)C)[C@]2(CO)[C@H](O)C[C@@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@H]6O[C@@H]([C@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@@H]6O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2CC1(C)C AXNVHPCVMSNXNP-BEJCRFBNSA-N 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001988 toxicity Effects 0.000 title abstract 3
- 231100000419 toxicity Toxicity 0.000 title abstract 3
- 241001444063 Aronia Species 0.000 abstract 4
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 abstract 2
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 230000002503 metabolic effect Effects 0.000 abstract 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 2
- 229930182490 saponin Natural products 0.000 abstract 2
- 150000007949 saponins Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1619846.7A GB201619846D0 (en) | 2016-11-24 | 2016-11-24 | Saponin composition |
| PCT/IB2017/057395 WO2018096502A1 (en) | 2016-11-24 | 2017-11-24 | Oral compositions comprising beta-escin for reducing acetaldehyde toxicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL430029A1 true PL430029A1 (pl) | 2021-03-08 |
Family
ID=58073282
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL430029A PL430029A1 (pl) | 2016-11-24 | 2017-11-24 | Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehydu |
| PL17812273.5T PL3544615T3 (pl) | 2016-11-24 | 2017-11-24 | Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17812273.5T PL3544615T3 (pl) | 2016-11-24 | 2017-11-24 | Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10799550B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3544615B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7070933B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102569055B1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017365116B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3044504A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201619846D0 (cg-RX-API-DMAC7.html) |
| PL (2) | PL430029A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018096502A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2992157T3 (es) * | 2018-10-05 | 2024-12-09 | Escilab Sp Z O O | Composición oral que comprende b-escina y el uso de la misma |
| CN116159145B (zh) * | 2023-01-31 | 2025-04-22 | 四川大学 | 含七叶皂苷和/或其盐化合物的转染复合物在促转染的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3533231B2 (ja) * | 1993-08-20 | 2004-05-31 | 森下仁丹株式会社 | アルコール吸収抑制剤 |
| JP4777495B2 (ja) * | 1999-04-01 | 2011-09-21 | 森下仁丹株式会社 | アルコール障害予防剤およびそれを含有する食品 |
| DK1976391T3 (da) * | 2005-12-30 | 2011-01-10 | Cadbury Holdings Ltd | Tyggegummipræparat indeholdende aroniabær |
| KR101383276B1 (ko) * | 2012-03-05 | 2014-04-08 | 염장열 | 아로니아 음료 농축액 및 그 제조방법 |
| KR20140090453A (ko) * | 2013-01-09 | 2014-07-17 | (주) 제이비케이자연의학연구소 | 아로니아 추출물을 함유하는 숙취예방, 숙취해소 또는 간 보호용 조성물 |
| PL405318A1 (pl) * | 2013-09-11 | 2015-03-16 | Cezary Bilski | Preparat złożony wspomagający odchudzanie na bazie wyciągów roślinnych |
| KR20160100572A (ko) * | 2015-02-16 | 2016-08-24 | 학교법인연세대학교 | 고미가 제거된 남가새 음료 및 이의 제조방법 |
| EP3078381A1 (en) * | 2015-04-10 | 2016-10-12 | Warszawski Uniwersytet Medyczny | Horse chestnut extract or escins for the treatment of alzheimer's disease |
-
2016
- 2016-11-24 GB GBGB1619846.7A patent/GB201619846D0/en not_active Ceased
-
2017
- 2017-11-24 PL PL430029A patent/PL430029A1/pl unknown
- 2017-11-24 AU AU2017365116A patent/AU2017365116B2/en active Active
- 2017-11-24 CA CA3044504A patent/CA3044504A1/en active Pending
- 2017-11-24 PL PL17812273.5T patent/PL3544615T3/pl unknown
- 2017-11-24 US US16/461,967 patent/US10799550B2/en active Active
- 2017-11-24 EP EP17812273.5A patent/EP3544615B1/en active Active
- 2017-11-24 WO PCT/IB2017/057395 patent/WO2018096502A1/en not_active Ceased
- 2017-11-24 JP JP2019528118A patent/JP7070933B2/ja active Active
- 2017-11-24 KR KR1020197014741A patent/KR102569055B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10799550B2 (en) | 2020-10-13 |
| JP7070933B2 (ja) | 2022-05-18 |
| AU2017365116B2 (en) | 2023-06-22 |
| JP2019535779A (ja) | 2019-12-12 |
| KR20190087437A (ko) | 2019-07-24 |
| US20190321432A1 (en) | 2019-10-24 |
| KR102569055B1 (ko) | 2023-08-21 |
| EP3544615B1 (en) | 2022-05-18 |
| PL3544615T3 (pl) | 2022-09-19 |
| EP3544615A1 (en) | 2019-10-02 |
| CA3044504A1 (en) | 2018-05-31 |
| WO2018096502A1 (en) | 2018-05-31 |
| AU2017365116A1 (en) | 2019-05-23 |
| GB201619846D0 (en) | 2017-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007081773A3 (en) | Treatment of fatty liver | |
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
| MY209059A (en) | Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone | |
| TN2015000555A1 (en) | Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase | |
| HRP20160406T1 (hr) | Postupci i pripravci za liječenje sa štitnjačom povezanih medicinskih stanja sa sniženiim folatima | |
| UA90668C2 (ru) | Состав для лечения хронической венозной недостаточности, который содержит водный экстракт листьев красного винограда и противовоспалительное средство | |
| PL430029A1 (pl) | Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehydu | |
| MX2022015799A (es) | Composicion y metodo para el tratamiento del dolor cronico. | |
| AR110800A1 (es) | MÉTODOS PARA AUMENTAR EN PLASMA SANGUÍNEO LA 2-DESOXIURIDINA (dUrd) Y LA INHIBICIÓN DE LA TIMIDILATO SINTASA | |
| BR112014000182A2 (pt) | mascaramento do amargor | |
| RU2019105734A (ru) | Фармацевтическая композиция для применения при лечении патологий простаты | |
| NO20075945L (no) | Behandling, prevensjon og ameliorasjon av lungelidelser assosiert med kjemoterapi eller radioterapi med aktive vitamin D sammensetninger eller imitatorer derav | |
| EA201992826A1 (ru) | 15бета-[3-пропанамидо]-замещенные эстра-1,3,5(10)-триен-17-оны и их 17-оксимы для применения в ингибировании 17бета-гидроксистероиддегидрогеназ | |
| HRP20211488T1 (hr) | Sastav i metoda za liječenje metaboličkih poremećaja | |
| HRP20250972T1 (hr) | Farmaceutski pripravak za prevenciju i/ili liječenje atopijskog dermatitisa koji sadrži il-31 antagonist kao djelatni sastojak | |
| MX2023000899A (es) | Administracion de beta-hidroxibutirato y compuestos relacionados en humanos para el tratamiento y/o prevencion de enfermedades respiratorias. | |
| MX2016008546A (es) | Reduccion de queloides utilizando alantoina topica. | |
| TW201511766A (zh) | 用於增進男性性健康之方法及組合物 | |
| DK1827136T3 (da) | Sammensætning til oral indgivelse med sundhedsfremmende virkning på hjerte-kredslöbs-systemet | |
| NZ733658A (en) | Compositions and methods for chronic use of a weight-gaining compound | |
| PL423673A1 (pl) | Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis | |
| PH12022553179A1 (en) | A pharmarceutical composition capable of inhibiting replication of coronavirus | |
| FI20135503A7 (fi) | Kysteiini tai sen johdannainen atrofisen gastriitin hoitamiseen | |
| DE60035771D1 (de) | Verwendung eines den plasma homocysteingehalt reduzierenden wirkstoffs zur verminderung des risikos der durch gestagen hormone verursachten thromboembolischen nebenwirkungen |